Phase
Condition
Soft Tissue Infections
Gynecological Infections
Sexually Transmitted Diseases (Stds)
Treatment
Levofloxacin 500mg
Sodium Hyaluronate
Clinical Study ID
Ages 18-50 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patient aged between 18 and 50 years
symptoms consistent with CBP
positive Mears-Stamey test
Exclusion
Exclusion Criteria:
patients younger than 18 years
history of neurological disease, urinary stones or cancer
allergy to fluoroquinolones or any components of Butirprost®
post-void residual > 50 mL
Use of alpha-blockers or 5-alpha-reductase inhibitors (5-ARI)
previous prostatic surgery, antibiotic treatment within four weeks prior to thestudy
refusal to provide informed consent and incomplete follow-up data
Patients testing positive for certain pathogens like Chlamydia trachomatis (Ct),Ureaplasma urealyticum, Neisseria gon-orrhoeae, herpes simplex virus types 1 and 2 (HSV-1/2), and human papillomavirus (HPV)
Study Design
Connect with a study center
University of Naples Federico II
Napoli, 80131
ItalySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.